Suppr超能文献

腹腔镜肝门部胆管癌根治术:单中心初步经验。

Total laparoscopic radical resection of hilar cholangiocarcinoma: preliminary experience of a single center.

机构信息

Department of General Surgery, Affiliated Hospital of Xuzhou Medical University, #99 Huai Xi Road, Jiangsu, Xuzhou, 221002, P. R. China.

出版信息

BMC Surg. 2024 Aug 24;24(1):241. doi: 10.1186/s12893-024-02533-w.

Abstract

BACKGROUND

The aim of this study was to describe our preliminary experience in the procedure of laparoscopic radical resection of hilar cholangiocarcinoma and to evaluate its feasibility, safety, and clinical efficacy.

METHODS

A retrospective analysis was conducted on 44 patients with hilar cholangiocarcinoma who underwent laparoscopic surgery at our hospital from August 2019 to September 2023. Clinical data were collected from these patients, including 13 cases of Bismuth type I, 17 cases of Bismuth type II, 5 cases of Bismuth type IIIa, and 9 cases of Bismuth type IIIb.

RESULTS

Laparoscopic radical resection of hilar cholangiocarcinoma was successfully performed in 38 patients (86.3%). Among the remaining patients, 3 required vascular reconstruction to complete radical surgery and were converted to laparotomies, while 3 others underwent T-tube drainage only due to unresectable metastases. The median operation time was 285 min (range, 190-450), and the median estimated blood loss was 360 mL (range, 260-1200). The postoperative hospital stay duration was 14.3 ± 3.6 days. No perioperative mortality was observed. Postoperative pathological examination revealed negative microscopic margins (R0) in 39 cases and positive microscopic margins (R1) in 2 cases. Postoperative complications occurred in 8 patients (18.1%), with 4 cases (9.0%) of Grade I, 3 cases (6.8%) of Grade II, 1 case (2.2%) of Grade IIIa, and no Grade IIIb or IV complications. The median overall survival for patients who underwent radical R0 resection was 30.4 months (range, 5.3-43.6). The Disease-free survival rates were 73.6% at 1 year, 61.2% at 2 years, and 40.1% at 3 years.

CONCLUSION

Total laparoscopic radical resection of hilar cholangiocarcinoma can be performed safely, feasibly, and effectively by experienced surgeons after an accurate preoperative evaluation.

摘要

背景

本研究旨在描述我们在腹腔镜肝门部胆管癌根治性切除术方面的初步经验,并评估其可行性、安全性和临床疗效。

方法

对 2019 年 8 月至 2023 年 9 月在我院行腹腔镜手术的 44 例肝门部胆管癌患者进行回顾性分析。收集患者的临床资料,包括 13 例 Bismuth Ⅰ型、17 例 Bismuth Ⅱ型、5 例 Bismuth Ⅲa 型和 9 例 Bismuth Ⅲb 型。

结果

38 例(86.3%)患者成功完成腹腔镜肝门部胆管癌根治性切除术。其余 3 例因血管重建需要转为开腹手术,3 例因不可切除转移灶仅行 T 管引流,均达到根治性切除。手术时间中位数为 285min(范围,190-450min),术中估计出血量中位数为 360ml(范围,260-1200ml)。术后住院时间为 14.3±3.6d。无围手术期死亡。术后病理检查显示 39 例(92.3%)切缘阴性(R0),2 例(4.7%)切缘阳性(R1)。术后发生并发症 8 例(18.1%),其中Ⅰ级 4 例(9.0%),Ⅱ级 3 例(6.8%),Ⅲa 级 1 例(2.2%),无Ⅲb 级或Ⅳ级并发症。行根治性 R0 切除的患者中位总生存时间为 30.4 个月(范围,5.3-43.6 个月)。1 年、2 年、3 年无病生存率分别为 73.6%、61.2%、40.1%。

结论

经验丰富的外科医生在准确的术前评估后,能够安全、可行、有效地完成腹腔镜肝门部胆管癌根治性切除术。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/090e/11344452/316a04b60758/12893_2024_2533_Figa_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验